Cosmetic cross-reference

Aspartame

CAS 22839-47-0

Aspartame (CAS 22839-47-0) is a Phase 3 pharmaceutical compound with 3 bioactivity targets and 3 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral / FAERS

Adverse signals

SOURCE IUPHAR / PharmGKB

PubMed IDs

SOURCE ChEMBL 36 B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Aspartame

CAS Number

22839-47-0

UNII

Z0H242BBR1

InChIKey

IAOZJIPTCAWIRG-QWRGUYRKSA-N

ChEMBL ID

CHEMBL171679

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE ChEMBL 36 B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3

Late-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL171679 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE ChEMBL 36 activities + assays 3 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	Potency	23299 nM	10	-
-	AC50	1335.7 nM	2	-
-	IC50	19976.309999999998 nM	1	-

SOURCE IUPHAR ligand-target interactions 1 interaction

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

Target	Action	Affinity	PubMed
TAS1R2 TAS1R2	Agonist	-	40339580

SOURCE RxNorm drug names 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
ASPARTAME	1311524	SU	MTHSPL
Aspartame	1311524	SU	MTHSPL
aspartame	1311524	SU	MTHSPL
aspartame	1311524	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Aspartame used for in pharmaceutical contexts?

Aspartame (CAS 22839-47-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Aspartame?

Aspartame has 3 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Muscle spasms, Pain, Product prescribing issue. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Aspartame also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Aspartame with EU status "permitted".

What clinical phase is Aspartame in?

Aspartame is rendered with ChEMBL max phase 3.